 |
인쇄하기
취소
|
Bukwang’s stocks attract local investors
Published: 2009-02-19 07:00:00
Updated: 2009-02-19 07:00:00
The share price of Bukwang Pharm has been on gradual increase as its investigational drug Levovir (clevudine) has been globally spotlighted these days.
Clevudine is an oral, once-daily pyrimidine nucleoside analog that has previously been evaluated in 14 clinical trials in more than 800 individuals.
According to the results of clinical trials reported in the 19th conference of the Asian ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.